Cargando…
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer
Oncolytic viruses (OVs) are promising therapeutics for tumors with a poor prognosis. An OV based on herpes simplex virus type 1 (oHSV-1), talimogene laherparepvec (T-VEC), has been recently approved by the Food and Drug Administration (FDA) and by the European Medicines Agency (EMA) for the treatmen...
Autores principales: | Reale, Alberto, Krutzke, Lea, Cadamuro, Massimiliano, Vitiello, Adriana, von Einem, Jens, Kochanek, Stefan, Palù, Giorgio, Parolin, Cristina, Calistri, Arianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253092/ https://www.ncbi.nlm.nih.gov/pubmed/37298206 http://dx.doi.org/10.3390/ijms24119255 |
Ejemplares similares
-
Chorioallantoic Membrane Tumor Model for Evaluating Oncolytic Viruses
por: Krutzke, Lea, et al.
Publicado: (2020) -
Perspectives on immunotherapy via oncolytic viruses
por: Reale, Alberto, et al.
Publicado: (2019) -
Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages
por: Sartori, Elena, et al.
Publicado: (2011) -
Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
por: Reale, Alberto, et al.
Publicado: (2021) -
A clinical trial investigating biodistribution and shedding of an oncolytic virus
por: Reale, Alberto, et al.
Publicado: (2019)